NYSE Euronext — Q2 2013 Earnings Presentation
20 slides from NYSE Euronext's earnings presentation, Jul 30, 2013
Slide 1: NYSE Euronext Second Quarter 2013 Earnings Presentation
NYSE EURONEXT SECOND QUARTER 2013 EARNINGS PRESENTATION July 30, 2013
Slide 2: Legal Disclaimers
LEGAL DISCLAIMERS Non-GAAP Financial Measures To supplement NYSE Euronext’s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that e
Slide 3: Legal Disclaimers
LEGAL DISCLAIMERS IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE TO FIND IT This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, ICE Group
Slide 4: 2Q13 Highlights
2Q13 HIGHLIGHTS Diluted non-GAAP EPS 2 of $0.63, up 24% vs. 2Q12; Up 11% vs. 1Q13 $611 million in net revenues 3, up versus both 2Q12 and 1Q13 Other operating expenses 4 of $382 million, down 5% on constant dollar / Our Results 1 portfolio basis Operating income 4 of $229 million, up 11% vs.
Slide 5: Derivatives Update
DERIVATIVES UPDATE EU US FICC Products ADV U.S. Equity Options ADV & Market Share ADV (Contracts) Mkt Share ADV (Contracts) 3,500,000 6,000,000 30% 3,000,000 5,000,000 25% 2,500,000 4,000,000 20% NYSE Arca 2,000,000 3,000,000 15% 1,500,000 2,000,000 10% NYSE Amex 1,000,000 1,000,000 5% 500,000 - - 0
Slide 6: Clearing Migration
CLEARING MIGRATION On July 1st, responsibility for the clearing of the London market of NYSE Liffe transitioned from NYSE Liffe Clearing (and LCH.Clearnet Ltd) to ICE Clear Europe The partnership with ICE Clear Europe brings the clearing arrangements for LIFFE in line with changing regulatory re
Slide 7: Cash Equities Update
CASH EQUITIES UPDATE European Cash U.S. Cash ADV trades in thousands ADV shares in millions ADV & Market Share ADV & Capture1 ADV Mkt Share ADV Capture 1 1,800 69.0% 1,850 $0.051 1,700 67.0% $0.048 1,750 1,600 65.0% $0.045 1,650 1,500 63.0% $0.042 1,400 61.0% $0.039 1,550 1,300 59.0% $0.036 1,450 1,
Slide 8: Strong Momentum in Listings
STRONG MOMENTUM IN LISTINGS #1 in global IPO and follow-on proceeds – more IPO and follow-on proceeds raised than next four competitors combined Leader in Technology IPOs – 14 companies raising $2.1B in proceeds, including Tableau Software, Gigamon, Light in the Box, and ChannelAdvisor Leader
Slide 9: ICE / NYX Transaction Timeline
ICE / NYX TRANSACTION TIMELINE Competition 5/17/13 Review Submission of Form CO 2/15/13 US competition 6/24/13 clearance under 5/1/2013 EC approves ICE the HSR Act EU prospectus transaction expired approval DEC 12 FEB APR MAY JUN AUG FALL 2013 06/3/13 12/20/12 4/30/13 ICE/NYX 8/15/131 Anticipated cl
Slide 10: GAAP 2Q13 Financial Results
GAAP 2Q13 FINANCIAL RESULTS ($ in millions, except per share data) 2Q13 1Q13 2Q12 Total Revenue¹ $995 $963 $986 Operating Income $207 $202 $194 Net Income $173 $126 $125 Diluted EPS $0.71 $0.52 $0.49 Pre-tax Adjustments 2Q13 1Q13 2Q12 Merger & Exit Costs ($22) ($8) ($12) Charge for RSU Fair Value Ad
Slide 11: Non-GAAP 2Q13 Financial Results
NON-GAAP 2Q13 FINANCIAL RESULTS ($ in millions, except per share data) % ∆ 2Q13 Year-to-Date % ∆ YTD13 2Q13 1Q13 2Q12 vs. 2Q12 2013 2012 vs. YTD12 Total Revenue¹ $995 $963 $986 1% $1,958 $1,938 1% Transaction-based Expenses² $384 $363 $384 − $747 $735 2% Total Revenues, Less Transaction-based Expens
Slide 12: F/X Impact by Segment
F/X IMPACT BY SEGMENT ($ in millions) Select Financial Highlights $ Variance Attribution 2Q13 2Q12 Total FX Specific Operational % Operational 1 Net Revenue $611 $602 $9 ($2) $11 2% Operating Expenses 2 ($382) ($396) $14 ($2) $12 (3%) Operating Income2 $229 $206 $23 $0 $23 11% F/X Impact by Segment
Slide 13: Derivatives Highlights
DERIVATIVES HIGHLIGHTS ($ in millions) % ∆ 2Q13 % ∆ YTD13 2Q13 1Q13 2Q12 vs. 2Q12 YTD2013 YTD2012 vs. YTD12 Total Revenue $285 $293 $240 19% $578 $469 23% Net Revenue¹ $195 $201 $182 7% $396 $358 11% % of total 32% 34% 30% 33% 30% Other Operating Expenses² $92 $97 $97 (5%) $189 $194 (3%) Operating I
Slide 14: Derivatives Trading Volumes & Capture
DERIVATIVES ($ in millions) TRADING VOLUMES & CAPTURE European Derivatives ADV Contracts in thousands 2Q12 3Q12 4Q12 1Q13 2Q13 6,000 4,654 Total Revenue $ 161 $ 143 $ 133 $ 195 $ 180 4,515 4,048 4,000 3,534 883 Liquidity Payments (37) (34) (32) (55) (51) 1,743 3,386 749 829 1,190 Routing and Clearin
Slide 15: Cash Trading & Listings Highlights
CASH TRADING & LISTINGS HIGHLIGHTS ($ in millions) % ∆ 2Q13 % ∆ YTD13 2Q13 1Q13 2Q12 vs. 2Q12 YTD2013 YTD2012 vs. YTD12 Total Revenue¹ $596 $558 $626 (5%) $1,154 $1,228 (6%) Net Revenue² $302 $287 $300 1% $589 $604 (2%) % of total 49% 48% 50% 49% 50% Other Operating Expenses3 $174 $173 $173 1% $347
Slide 16: Cash Trading Volumes & Capture
CASH TRADING VOLUMES & CAPTURE ($ in millions) European Cash ADV Trades in thousands 2Q12 3Q12 4Q12 1Q13 2Q13 2,000 1,709 Total Revenue $ 55 $ 46 $ 44 $ 53 $ 52 1,378 1,470 1,500 1,318 Liquidity Payments - - - - - 1,179 Routing and Clearing - - - - - 1,000 Net Revenue $ 55 $ 46 $ 44 $ 53 $ 52 500 Re
Slide 17: Info. Svcs. & Tech. Solutions Highlights
INFO. SVCS. & TECH. SOLUTIONS HIGHLIGHTS ($ in millions) % ∆ 2Q13 % ∆ YTD13 2Q13 1Q13 2Q12 vs. 2Q12 YTD2013 YTD2012 vs. YTD12 Total Revenue $114 $112 $119 (4%) $226 $240 (6%) % of total 19% 19% 20% 19% 20% Other Operating Expenses1 $89 $87 $92 (3%) $176 $185 (5%) Operating Income1 $25 $25 $27 (7%) $
Slide 18: P14 Operating Expense Reconciliation & FY 2013 Guidance
P14 OPERATING EXPENSE RECONCILIATION & FY 2013 GUIDANCE ($ in millions) Project 14 Base Trailing FY Guidance Other Operating Expenses¹ 2011 12 Months 2013 Non-GAAP Expenses ($1,666) ($1,539) ($1,525) P14 Currency Rates Adjustment2 - ($18) ($15) Non-GAAP Expenses Rebased ($1,666) ($1,557) ($1,540) Im
Slide 19: Strong Balance Sheet & Liquidity
STRONG BALANCE SHEET & LIQUIDITY ($ in billions) Cash & Investment Securities $0.3 Total Debt $2.2 Key ► 2.0% $850m notes due Oct 2017 $0.9 ► 5.375% €1bn notes due June 2015 $1.1 Balance Sheet ► Commercial paper in $ and € $0.2 Indicators as of Net Debt $1.9 6/30/2013 Total Debt/EBITDA 1.9X Credit R
Slide 20: Slide 20